FORBES MEDI TECH RES INC has a total of 25 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are MJALLI ADNAN M M, GOMPEL MARIE and TRANSTECH PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | Canada | 3 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Environmental technology | |
#6 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Nestor John | 20 |
#2 | John Nestor | 2 |
#3 | Nestor John J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008046071A2 | Compounds and methods of treating metabolic syndrome and inflammation | |
US2008214440A1 | Vasoactive intestinal polypeptide compositions | |
WO2008043102A2 | Vasoactive intestinal polypeptide compositions | |
US2008096799A1 | Compounds for and methods of treating insulin resistance and inflammation | |
US2007135450A1 | Compounds and Methods of Treating Insulin Resistance and Cardiomyopathy | |
CA2638968A1 | Vasoactive intestinal polypeptide pharmaceuticals | |
CN101060845A | Compounds and methods of treating insulin resistance and cardiomyopathy | |
US2006079542A1 | Compounds and methods for treating insulin resistance and cardiomyopathy | |
BRPI0516126A | vasoactive intestinal polypeptide pharmaceuticals |